Breaking News Instant updates and real-time market news.

VRTX

Vertex

$87.65

1.23 (1.42%)

08:38
10/06/16
10/06
08:38
10/06/16
08:38

Vertex Orkambi checks positive, says JMP Securities

After conducting checks with doctors, JMP Securities analyst Liisa Bayko says that uptake of Vertex's Orkambi drug among 6-11 year old children appears to be "rapid." Bayko expects Orkambi's market share in the age range to reach 70% within six months. She reiterates a $103 price target and Outperform rating on the stock.

  • 07

    Oct

  • 06

    Nov

VRTX Vertex
$87.65

1.23 (1.42%)

09/15/16
STFL
09/15/16
NO CHANGE
STFL
Vertex weakness creates attractive entry point, says Stifel
After Vertex made a number of negative announcements about its Orkambi drug, including its statement that the drug has "reached pretty much peak penetration in the U.S.," Stifel analyst Adam Walsh noted that the company also said that no chest tightness "has been observed to date with VX-661/Kalydeco." The analyst indicates that he believes that this attribute should enable those patients not taking Orkambi due to side effects to use VX-661/Kalydeco. He raised his price target on Vertex to $109 from $105 and says that the stock has reached an attractive entry point.
09/22/16
PIPR
09/22/16
NO CHANGE
Target $129
PIPR
Overweight
Vertex recent weakness brings buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff views the weakness in shares of Vertex Pharmaceuticals following the company's recent Q3 guidance as a buying opportunity ahead of Orkambi's September 30 PDUFA date in homozygous F508del children. Label expansion for Orkambi should drive cystic fibrosis sales to $478M in Q4, Tenthoff tells investors in a research note. He points out that Vertex will announce data at the North American Cystic Fibrosis Conference from October 27-29. The analyst reiterates an Overweight rating on the shares with a $129 price target.
09/29/16
RBCM
09/29/16
NO CHANGE
RBCM
Vertex should be bought on weakness, says RBC Capital
After Vertex lowered its 2016 Orkambi revenue guidance, RBC Capital analyst Michael Yee says that the news "was not a surprise." The analyst remains upbeat on the company's triple CF treatment, and he recommends buying the stock on weakness. He keeps an Outperform rating on the shares.
09/29/16
JMPS
09/29/16
NO CHANGE
JMPS
Vertex Orkambi approval should drive growth, says JMP Securities
JMP Securities analyst Liisa Bayko says that FDA approval of Vertex's Orkambi in the 6-11 year old population should enable the company to grow in Q4 after a temporary slowdown in Q3. However, the analyst expects Q4 Orkambi sales to come in at $285M, versus the consensus outlook of $295M. She keeps a $103 price target and Outperform rating on the shares.

TODAY'S FREE FLY STORIES

12:45
02/28/17
02/28
12:45
02/28/17
12:45
General news
Euro$ interest rate futures are above lows »

Euro$ interest rate…

XLF

Financial Select Sector

$24.39

-0.165 (-0.67%)

12:41
02/28/17
02/28
12:41
02/28/17
12:41
Options
Defensive short-term play opened in SPDR Financial ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$81.38

-0.1565 (-0.19%)

12:37
02/28/17
02/28
12:37
02/28/17
12:37
Syndicate
Exxon Mobil registers 68M shares of common stock related to private placement »

On January 16, 2017, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

SYRX

Sysorex

$0.23

0.0066 (2.93%)

, INPX

Inpixon

12:35
02/28/17
02/28
12:35
02/28/17
12:35
Hot Stocks
Sysorex gets favorable listing decision, effects split, changes name to Inpixon »

Sysorex announced it has…

SYRX

Sysorex

$0.23

0.0066 (2.93%)

INPX

Inpixon

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$58.66

-8.2475 (-12.33%)

, CVI

CVR Energy

$22.87

0.72 (3.25%)

12:33
02/28/17
02/28
12:33
02/28/17
12:33
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

TGT

Target

$58.66

-8.2475 (-12.33%)

CVI

CVR Energy

$22.87

0.72 (3.25%)

CVRR

CVR Refining

$11.40

0.55 (5.07%)

DK

Delek US

$24.76

1.78 (7.75%)

HFC

HollyFrontier

$29.48

0.9725 (3.41%)

PBF

PBF Energy

$24.62

1.18 (5.03%)

VLO

Valero

$69.32

2.08 (3.09%)

PCLN

Priceline

$1,632.01

0.39 (0.02%)

HTZ

Hertz

$21.54

1.54 (7.70%)

SBY

Silver Bay Realty

$21.49

3.315 (18.24%)

GME

GameStop

$25.17

-1.35 (-5.09%)

MSFT

Microsoft

$64.23

-0.39 (-0.60%)

VRX

Valeant

$15.07

-1.64 (-9.81%)

SIG

Signet Jewelers

$66.97

-5.91 (-8.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

  • 09

    Mar

  • 14

    Mar

  • 14

    Mar

  • 19

    Mar

  • 09

    May

12:30
02/28/17
02/28
12:30
02/28/17
12:30
General news
Breaking General news story  »

Kansas City Federal…

MINI

Mobile Mini

$33.45

-0.35 (-1.04%)

12:28
02/28/17
02/28
12:28
02/28/17
12:28
Hot Stocks
Mobile Mini rebrands Evergreen Tank Solutions, Water Movers units »

Mobile Mini announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ORBC

ORBCOMM

$8.18

0.06 (0.74%)

12:27
02/28/17
02/28
12:27
02/28/17
12:27
Hot Stocks
ORBCOMM says partner wins multi-year contract with Canada »

ORBCOMM announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LIOX

Lionbridge

$5.75

0.01 (0.17%)

12:26
02/28/17
02/28
12:26
02/28/17
12:26
Hot Stocks
Lionbridge announces tockholder approval of HIG Capital acquisition »

Lionbridge Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

XOM

Exxon Mobil

$81.42

-0.125 (-0.15%)

12:25
02/28/17
02/28
12:25
02/28/17
12:25
Syndicate
Breaking Syndicate news story on Exxon Mobil »

Exxon Mobil files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

TV

Grupo Televisa

$25.73

-1.06 (-3.96%)

12:21
02/28/17
02/28
12:21
02/28/17
12:21
Options
Put seller opens a notable new position in Grupo Televisa »

Put seller opens a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHT

DHT Holdings

$4.66

-0.015 (-0.32%)

, FRO

Frontline

$6.92

0.19 (2.82%)

12:20
02/28/17
02/28
12:20
02/28/17
12:20
Hot Stocks
DHT says rejects revised Frontline bid, offers to meet with company »

DHT Holdings (DHT)…

DHT

DHT Holdings

$4.66

-0.015 (-0.32%)

FRO

Frontline

$6.92

0.19 (2.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 22

    Mar

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

12:20
02/28/17
02/28
12:20
02/28/17
12:20
Hot Stocks
Breaking Hot Stocks news story on Signet Jewelers »

Signet Jewelers trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

SRAX

Social Reality

$2.58

-0.02 (-0.77%)

12:19
02/28/17
02/28
12:19
02/28/17
12:19
Hot Stocks
Breaking Hot Stocks news story on Social Reality »

Martin A. Sumichrast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

12:18
02/28/17
02/28
12:18
02/28/17
12:18
Hot Stocks
Breaking Hot Stocks news story on Signet Jewelers »

Signet Jewelers trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

$NSD

NASDAQ Market Internals

12:17
02/28/17
02/28
12:17
02/28/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/28/17
02/28
12:16
02/28/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$42.64

-0.43 (-1.00%)

12:07
02/28/17
02/28
12:07
02/28/17
12:07
Periodicals
PayPal sued over treatment of charity donations, CNBC reports »

PayPal has been sued in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

ARTNA

Artesian Resources

$32.99

0.28 (0.86%)

12:04
02/28/17
02/28
12:04
02/28/17
12:04
Hot Stocks
Artesian Water agrees to acquire water assets of FDRPC »

Artesian Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$102.26

-0.63 (-0.61%)

12:04
02/28/17
02/28
12:04
02/28/17
12:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.32

-0.155 (-1.35%)

12:01
02/28/17
02/28
12:01
02/28/17
12:01
Options
Defensive option play opened in the US Oil Fund »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIG

Signet Jewelers

$66.85

-6.03 (-8.27%)

11:58
02/28/17
02/28
11:58
02/28/17
11:58
Hot Stocks
Signet's Sterling calls media reports 'distorted and inaccurate' »

Sterling Jewelers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

ACH

Aluminum Corp. of China

$12.44

-0.18 (-1.43%)

11:55
02/28/17
02/28
11:55
02/28/17
11:55
Upgrade
Aluminum Corp. of China rating change  »

Aluminum Corp. of China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
02/28/17
02/28
11:55
02/28/17
11:55
General news
Treasury's bill auctions saw rather tepid results »

Treasury's bill…

P

Pandora

$12.59

-0.585 (-4.44%)

, LMCA

Liberty Media

11:54
02/28/17
02/28
11:54
02/28/17
11:54
Hot Stocks
Pandora lower after Liberty Media CEO comments on valuation »

Shares of Pandora Media…

P

Pandora

$12.59

-0.585 (-4.44%)

LMCA

Liberty Media

SIRI

Sirius XM

$5.18

0.06 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.